Clinical and Experimental Ophthalmology

Papers
(The H4-Index of Clinical and Experimental Ophthalmology is 24. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Continuing Professional Development236
Issue Information119
Issue Information95
Stromal Curvature, Power and Corneal‐Stromal Curvature Ratios From a Hybrid AS‐OCT in Eyes With Keratoconus81
Fluid misdirection syndrome associated with endothelial keratoplasty: A multicenter case series69
The Long Journey of Treatment for Wet Macular Degeneration, Is It Worth It?69
Recent advances in the use of optical coherence tomography in neuro‐ophthalmology: A review62
Circular RNA expression profile and functional analysis of circUvrag in light‐induced photoreceptor degeneration60
Improved methods for isolating the mouse retinal vasculature50
Genetics in neovascular age‐related macular degeneration susceptibility and treatment response to anti‐VEGF intravitreal injection: A case series study44
Proposal of a Simpler Eye‐Level Risk Model Incorporating Reticular Pseudodrusen for the Clinical Prediction of Late Age‐Related Macular Degeneration44
Mimickers of hydroxychloroquine retinal toxicity42
The association between keratoconus and allergic eye diseases: A systematic review and meta‐analysis42
Issue Information40
Telemedicine and delivery of ophthalmic care in rural and remote communities: Drawing from Australian experience40
Continuing Professional Development39
34
Continuing Professional Development29
Optimised minus lens overcorrection for paediatric intermittent exotropia: A randomised clinical trial27
Continuing Professional Development27
Issue Information27
Publishing opportunities and gender equity: Embedding monitoring in eye health education26
Bevacizumab biosimilar (bevacizumab‐awwb) is safe in the treatment of retinopathy of prematurity24
‘Closing the gap’ on visual acuity outcomes of Indigenous and remote patients receiving intravitreal injections in Northern Australia24
0.082541942596436